(Q37119421)

English

A retrospective review of combination chemohormonal therapy as initial treatment for locally advanced or metastatic adenocarcinoma of the prostate

scientific article published on 04 March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

A retrospective review of combination chemohormonal therapy as initial treatment for locally advanced or metastatic adenocarcinoma of the prostate (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

1 reference

based on heuristic

inferred from title

metastatic adenocarcinoma

1 reference

based on heuristic

inferred from title

author name string

Robert J Amato

1

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Bin S Teh

2

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Haby Henary

3

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Muhammad Khan

4

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Somyata Saxena

5

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

publication date

4 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

165-169

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.12.004

7 January 2021

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.12.004

7 January 2021

Postoperative adjuvant and salvage radiotherapy for prostate cancer: impact on freedom from biochemical relapse and survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.12.004

7 January 2021

Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.12.004

7 January 2021

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.12.004

7 January 2021

The clinical usefulness of serum prostate specific antigen after hormonal therapy of metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.12.004

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.12.004

7 January 2021

Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.12.004

7 January 2021

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.12.004

7 January 2021

Combined versus sequential chemo-endocrine therapy in advanced prostate cancer: final results of a randomized Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.12.004

7 January 2021

Effect of docetaxel in patients with hormone-dependent prostate-specific antigen progression after local therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.12.004

7 January 2021

Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.12.004

7 January 2021

Estramustine and vinblastine for patients with progressive androgen-independent adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.12.004

7 January 2021

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.12.004

7 January 2021

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.12.004

7 January 2021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.12.004

7 January 2021

Docetaxel followed by hormone therapy in men experiencing increasing prostate-specific antigen after primary local treatments for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.12.004

7 January 2021

Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.12.004

7 January 2021

Phase II study of the oral cyclophosphamide and oral etoposide combination in hormone-refractory prostate carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.12.004

7 January 2021

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.12.004

7 January 2021

Identifiers

10.1016/J.UROLONC.2007.12.004

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37119421&oldid=1687162267"